Sarepta Therapeutics
SRPT
#1466
Rank
โ‚น1.019 T
Marketcap
โ‚น10,675
Share price
-0.81%
Change (1 day)
36.86%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Net assets

Net assets on the balance sheet as of September 2024 : โ‚น103.64 Billion

According to Sarepta Therapeutics 's latest financial reports the company has โ‚น103.64 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sarepta Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$โ‚น71.53 B124.58%
2022-12-31$โ‚น31.85 B-53.88%
2021-12-31$โ‚น69.07 B23.99%
2020-12-31$โ‚น55.71 B-4.52%
2019-12-31$โ‚น58.34 B-19.17%
2018-12-31$โ‚น72.17 B43.24%
2017-12-31$โ‚น50.39 B120.25%
2016-12-31$โ‚น22.87 B80.87%
2015-12-31$โ‚น12.64 B-19.41%
2014-12-31$โ‚น15.69 B2.78%
2013-12-31$โ‚น15.27 B125.52%
2012-12-31$โ‚น6.77 B312.71%
2011-12-31$โ‚น1.64 B-1399.85%
2010-12-31$-โ‚น0.13 Billion-111.51%
2009-12-31$โ‚น1.09 B45%
2008-12-31$โ‚น0.75 B-26.97%
2007-12-31$โ‚น1.03 B-38.01%
2006-12-31$โ‚น1.67 B-30.83%
2005-12-31$โ‚น2.41 B112.25%
2004-12-31$โ‚น1.13 B-42.42%
2003-12-31$โ‚น1.97 B75.46%
2002-12-31$โ‚น1.12 B-23.57%
2001-12-31$โ‚น1.47 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚น1.560 T 1,406.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น44.69 Billion-143.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น127.61 B 23.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น39.78 Billion-138.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.74 B-97.35%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น89.5 Billion-186.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น41.03 B-60.41%๐Ÿ‡บ๐Ÿ‡ธ USA